Have you read How to Prevent the Next Pandemic by Bill Gates yet? Well, I have, and let me tell you: it’s every bit as infuriating, nauseating, ridiculous, laughable and risible as you would expect. Here are the details.
Tens of billions, soon to be much more, are flying out of US coffers to Ukraine as Americans suffer, showing who runs the government.
Joe Biden speaks about the conflict in Ukraine during a visit to Lockheed Martins’ Pike County Operations facility on May 3, 2022 (Photo: Nicholas Kamm/AFP via Getty Images)
From the start of the Russian invasion of Ukraine on February 24, the Biden White House has repeatedly announced large and seemingly random amounts of money that it intends to send to fuel the war in Ukraine. The latest such dispatch of large amounts of U.S. funds, pursuant to an initial $3.5 billion fund authorized by Congress early on, was announced on Friday; “Biden says U.S. will send $1.3 billion in additional military and economic support to Ukraine,” read the CNBC headline. This was preceded by a series of new lavish spending packages for the war, unveiled every two to three weeks, starting on the third day of the war:
Feb. 26: “Biden approves $350 million in military aid for Ukraine”: Reuters;
Mar. 16: “Biden announces $800 million in military aid for Ukraine”: The New York Times ;
Mar. 30: “Ukraine to receive additional $500 million in aid from U.S., Biden announces”: NBC News;
Apr. 12: “U.S. to announce $750 million more in weapons for Ukraine, officials say”: Reuters ;
May 6: “Biden announces new $150 million weapons package for Ukraine”: Reuters.
Those amounts by themselves are in excess of $3 billion; by the end of April, the total U.S. expenditure on the war in Ukraine was close to $14 billion, drawn from the additional $13.5 billion Congress authorized in mid-March. While some of that is earmarked for economic and humanitarian assistance for Ukraine, most of it will go into the coffers of the weapons industry — including Raytheon, on whose Board of Directors the current Secretary of Defense, Lloyd Austin, sat immediately before being chosen by Biden to run the Pentagon. As CNN put it: “about $6.5 billion, roughly half of the aid package, will go to the US Department of Defense so it can deploy troops to the region and send defense equipment to Ukraine.”
As enormous as those sums already are, they were dwarfed by the Biden administration’s announcement on April 28 that it “is asking Congress for $33 billion in funding to respond to the Russian invasion of Ukraine, more than double the $14 billion in support authorized so far.” The White House itself acknowledges that the vast majority of that new spending package will go to the purchase of weaponry and other military assets: “$20.4 billion in additional security and military assistance for Ukraine and for U.S. efforts to strengthen European security in cooperation with our NATO allies and other partners in the region.”
It is difficult to put into context how enormous these expenditures are — particularly since the war is only ten weeks old, and U.S. officials predict/hope that this war will last not months but years. That ensures that the ultimate amounts will be significantly higher still.
The amounts allocated thus far — the new Biden request of $33 billion combined with the $14 billion already spent — already exceed the average annual amount the U.S. spent for its own war in Afghanistan ($46 billion). In the twenty-year U.S. war in Afghanistan which ended just eight months ago, there was at least some pretense of a self-defense rationale given the claim that the Taliban had harbored Osama bin Laden and Al Qaeda at the time of the 9/11 attack. Now the U.S. will spend more than that annual average after just ten weeks of a war in Ukraine that nobody claims has any remote connection to American self-defense.
Even more amazingly, the total amount spent by the U.S. on the Russia/Ukraine war in less than three months is close to the Russia’s total military budget for the entire year($65.9 million). While Washington depicts Russia as some sort of grave and existential menace to the U.S., the reality is that the U.S. spends more than ten times on its military what Russia spends on its military each year; indeed, the U.S. spends three times more than the second-highest military spender, China, and more than the next twelve countries combined.
But as gargantuan as Biden’s already-spent and newly requested sums are — for a ten-week war in which the U.S. claims not to be a belligerent — it was apparently woefully inadequate in the eyes of the bipartisan establishment in Congress, who is ostensibly elected to serve the needs and interests of American citizens, not Ukrainians. Leaders of both parties instantly decreed that Biden’s $33 billion request was not enough. They thus raised it to $40 billion — a more than 20% increase over the White House’s request — and are now working together to create an accelerated procedure to ensure immediate passage and disbursement of these weapons and funds to the war zone in Ukraine. “Time is of the essence – and we cannot afford to wait,” House Speaker Nancy Pelosi said in a letter to House members, adding: “This package, which builds on the robust support already secured by Congress, will be pivotal in helping Ukraine defend not only its nation but democracy for the world.”
We have long ago left the realm of debating why it is in the interest of American citizens to pour our country’s resources into this war, to say nothing of risking a direct war and possibly catastrophic nuclear escalation with Russia, the country with the largest nuclear stockpile, with US close behind. Indeed, one could argue that the U.S. government entered this war and rapidly escalated its involvement without this critical question — which should be fundamental to any policy decision of the U.S. government — being asked at all.
This omission — a failure to address how the interests of ordinary Americans are served by the U.S. government’s escalating role in this conflict — is particularly glaring given the steadfast and oft-stated view of former President Barack Obama that Ukraine is and always will be of vital interest to Russia, but is not of vital interest to the U.S. For that reason, Obama repeatedly resisted bipartisan demands that he send lethal arms to Ukraine, a step he was deeply reluctant to take due to his belief that the U.S. should not provoke Moscow over an interest as remote as Ukraine (ironically, Trump — who was accused by the U.S. media for years of being a Kremlin asset, controlled by Putin through blackmail — did send lethal arms to Ukraine despite how provocative doing so was to Russia).
While it is extremely difficult to isolate any benefit to ordinary American citizens from all of this, it requires no effort to see that there is a tiny group of Americans who do benefit greatly from this massive expenditure of funds. That is the industry of weapons manufacturers. So fortunate are they that the White House has met with them on several occasions to urge them to expand their capacity to produce sophisticated weapons so that the U.S. government can buy them in massive quantities:
Top U.S. defense officials will meet with the chief executives of the eight largest U.S. defense contractors to discuss industry’s capacity to meet Ukraine’s weapons needs if the war with Russia continues for years.
Deputy Defense Secretary Kathleen Hicks told reporters Tuesday she plans to participate in a classified roundtable with defense CEOs on Wednesday to discuss “what can we do to help them, what do they need to generate supply”….
“We will discuss industry proposals to accelerate production of existing systems and develop new, modernized capabilities critical to the Department’s ongoing security assistance to Ukraine and long-term readiness of U.S. and ally/partner forces,” the official added.
On May 3, Biden visited a Lockheed Martin facility (see lead photo) and “praised the… plant that manufactures Javelin anti-tank missiles, saying their work was critical to the Ukrainian war effort and to the defense of democracy itself.”
Indeed, by transferring so much military equipment to Ukraine, the U.S. has depleted its own stockpiles, necessitating their replenishment with mass government purchases. One need not be a conspiracy theorist to marvel at the great fortune of this industry, having lost their primary weapons market just eight months ago when the U.S. war in Afghanistan finally ended, only to now be gifted with an even greater and more lucrative opportunity to sell their weapons by virtue of the protracted and always-escalating U.S. role in Ukraine. Raytheon, the primary manufacturer of Javelins along with Lockheed, has been particularly fortunate that its large stockpile, no longer needed for Afghanistan, is now being ordered in larger-than-ever quantities by its former Board member, now running the Pentagon, for shipment to Ukraine. Their stock prices have bulged nicely since the start of the war:
But how does any of this benefit the vast majority of Americans? Does that even matter? As of 2020, almost 30 million Americans are without any health insurance. Over the weekend, USA Today warned of “the ongoing infant formula shortage,” in which “nearly 40% of popular baby formula brands were sold out at retailers across the U.S. during the week starting April 24.” So many Americans are unable to afford college for their children that close to a majority are delaying plans or eliminating them all together. Meanwhile, “monthly poverty remained elevated in February 2022, with a 14.4 percent poverty rate for the total US population… Overall, 6 million more individuals were in poverty in February relative to December.” The latest data from the U.S. Census Bureau found that “approximately 42.5 million Americans [are] living below the poverty line.” Americans with diabetes often struggle to buy life-saving insulin. And on and on and on.
Now, if the U.S. were invaded or otherwise attacked by another country, or its vital interests were directly threatened, one would of course expect the U.S. government to expend large sums in order to protect and defend the national security of the country and its citizens. But can anyone advance a cogent argument, let alone a persuasive one, that Americans are somehow endangered by the war in Ukraine? Clearly, they are far more endangered by the U.S. response to the war in Ukraine than the war itself; after all, a nuclear confrontation between the U.S. and Russia has long been ranked by the Bulletin of Atomic Scientists as one of the two greatest threats facing humanity.
One would usually expect the American left, or whatever passes for it these days, to be indignant about the expenditure of tens of billions of dollars for weapons while ordinary Americans suffer. But the American left, such that it exists, is barely visible when it comes to debates over the war in Ukraine, while American liberals stand in virtual unity with the establishment wing of the Republican Party behind the Biden administration in support for the escalating U.S. role in the war in Ukraine. A few stray voices (such as Noam Chomsky) have joined large parts of the international left in urging a diplomatic solution in lieu of war and criticizing Biden for insufficient efforts to forge one, but the U.S. left and American liberals are almost entirely silent if not supportive.
That has left the traditionally left-wing argument about war opposition to the populist right. “You can’t find baby formula in the United States right now but Congress is voting today to send $40 billion to Ukraine,” said Donald Trump, Jr. on Tuesday, echoing what one would expect to hear from the 2016 version of Bernie Sanders or the pre-victory AOC. “In the America LAST $40 BILLION Ukraine FIRST bill that we are voting on tonight, there is authorization for funds to be given to the CIA for who knows what and who knows how much? But NO BABY FORMULA for American mothers!,” explained Rep. Marjorie Taylor Greene (R-GA). Christian Walker, the conservative influencer and son of GOP Senate candidate Herschel Walker in Georgia, today observed: “Biden should go apply to be the President of Ukraine since he clearly cares more about them than the U.S.” Chomsky himself caused controversy last week when he said that there is only one statesman of any stature in the West urging a diplomatic solution “and his name is Donald J. Trump.”
Meanwhile, the only place where dissent is heard over the Biden administration’s war policy is on the 8:00 p.m. and 10:00 p.m. programs on Fox News, hosted, respectively, by Tucker Carlson and Laura Ingraham, who routinely demand to know how ordinary Americans are benefiting from this increasing U.S. involvement. On CNN, NBC, and in the op-ed pages of The New York Times and The Washington Post, there is virtually lockstep unity in favor of the U.S. role in this war; the only question that is permitted, as usual, is whether the U.S. is doing enough or whether it should do more.
That the U.S. has no legitimate role to play in this war, or that its escalating involvement comes at the expense of American citizens, the people they are supposed to be serving, provokes immediate accusations that one is spreading Russian propaganda and is a Kremlin agent. That is therefore an anti-war view that is all but prohibited in those corporate liberal media venues. Meanwhile, mainstream Democratic House members, such as Rep. Jason Crow (D-CO), are now openly talking about the war in Ukraine as if it is the U.S.’s own:
Whatever else is true, the claim with which we are bombarded by the corporate press — the two parties agree on nothing; they are constantly at each other’s throats; they have radically different views of the world — is patently untrue, at least when it comes time for the U.S. to join in new wars. Typically, what we see in such situations is what we are seeing now: the establishment wings of both parties are in complete lockstep unity, always breathlessly supporting the new proposed U.S. role in any new war, eager to empty the coffers of the U.S. Treasury and transfer it to the weapons industry while their constituents suffer.
One can believe that Russia’s invasion of Ukraine is profoundly unjust and has produced horrific outcomes while still questioning what legitimate interests the U.S. has in participating in this war to this extent. Even if one fervently believes that helping Ukrainians fight Russia is a moral good, surely the U.S. government should be prioritizing the ability of its own citizens to live above the poverty line, have health insurance, send their kids to college, and buy insulin and baby formula.
There are always horrific wars raging, typically with a clear aggressor, but that does not mean that the U.S. can or should assume responsibility for the war absent its own vital interests and the interests of its citizens being directly at stake. In what conceivable sense are American citizens benefiting from this enormous expenditure of their resources and the increasing energy and attention being devoted by their leaders to Ukraine rather than to their lives and the multi-pronged deprivations that define it?
The U.S. Food and Drug Administration’s (FDA) top vaccine official told a congressional committee on Friday that COVID-19 vaccines for kids under 6 will not have to meet the agency’s 50% efficacy threshold required to obtain Emergency Use Authorization (EUA).
The FDA is reviewing data from Moderna’s two-shot vaccine for infants and toddlers 6 months to 2 years old, and for children 2 to 6 years old.
The agency is awaiting data on Pfizer and BioNTech’s three-dose regimen for children under age 5 after two doses of its pediatric vaccine failed to trigger an immune response in 2-, 3- and 4-year-olds comparable to the response generated in teens and adults.
According to Endpoints News, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, told the House Select Subcommittee on the Coronavirus Crisis the agency would not withhold authorization of a pediatric vaccine if it fails to meet the agency’s 50% efficacy threshold for blocking symptomatic infections.
COVID-19 vaccines for adolescents, teens and adults had to meet the requirement.
“If these vaccines seem to be mirroring efficacy in adults and just seem to be less effective against Omicron like they are for adults, we will probably still authorize,” Marks said.
The FDA on June 30, 2020, issued guidance that in order for an experimental COVID-19 vaccine to obtain EUA, it must “prevent disease or decrease its severity in at least 50 percent of people who are vaccinated.”
The guidelines were issued during a briefing with the Senate Committee on Health, Education, Labor and Pensions, during which senators sought assurances from former FDA Commissioner Stephen Hahn, Dr. Anthony Fauci and other top health officials that the expedited speed of development of COVID-19 vaccines wouldn’t compromise the integrity of the final product.
All previously authorized COVID-19 vaccines and boosters for all age groups were required to meet the FDA’s 50% requirement prior to obtaining EUA.
Vinay Prasad, a hematologist-oncologist and associate professor of Epidemiology and Biostatistics at the University of California, San Francisco posted a video responding to the news the FDA would bypass its own standard to authorize pediatric COVID-19 vaccines for kids.
Prasad said:
“Peter Marks from the FDA — he’s the defacto regulator-in-chief when it comes to vaccines — is saying that kids’ vaccines don’t need to hit the target. They don’t need to hit the 50% vaccine efficacy against symptomatic SARS-CoV-2 target. That was the target that the FDA themselves came up with in the original pandemic.
“They came up with this target 50% point estimate above, and the lower bound to the 95% confidence interval has to be above 30%. That was their minimum efficacy standard for vaccination. That was the standard they themselves set and that was the standard initial vaccine trials did clear for adults.
“But the pediatric vaccine trials — both the Pfizer and Moderna — appear not to have cleared that bar, and Peter Marks is talking to congressional officials and he is saying that it’s okay, we’ll probably authorize it anyway.”
Vasad said it was “incredible” that Marks would sign off on a pediatric vaccine if it seems to be mirroring efficacy in adults but is less effective against Omicron.
“We have standards for a reason,” Vasad said. The standard chosen by the FDA was “arbitrary and if anything I’d argue it was on the low side — 50% isn’t as good as what we wanted,” Vasad said.
“Fifty percent is quite low, and if you have a very low vaccine efficacy […] you can have compensatory behavior that actually leads to a lot more viral spread,” he added.
Vasad said when it comes to kids, it’s “kind of a moot point” because estimates from the Centers for Disease Control and Prevention from a few months ago showed 75% of children had zero prevalence — and it’s “probably higher now.”
“Taking a child under the age of 5 who already had and recovered from COVID and trying to make them better off with a vaccine against the original Wuhan ancestral strain — that’s an uphill battle,” Vasad said.
“The absolute upper bound, absolute risk reduction, has got to be super super low because once kids have it and recover from it they generally do pretty well. If they get it again they do even better than the first time.”
Lowering the regulatory standards for vaccine products is not the direction FDA should go, Vasad said. “They need to be upholding the standards they’ve set and raising the standards.”
Vasad raised concerns over what the standard will be moving forward if the agency doesn’t abide by its own minimum requirement.
“At what point will vaccine efficacy arrive at something the agency doesn’t accept?” He asked.
Vasad said once the FDA does away with EUA, many preschools will immediately mandate COVID-19 vaccines, and they won’t make exceptions for natural immunity or provide any exceptions at all.
“And so what he’s talking about is authorizing a vaccine in a setting where you have 75% minimum zero prevalence and the vaccine efficacy could be less than 50%,” Vasad said. “How much less?”
Pointing to a Moderna press release stating one arm of its trial showed its pediatric vaccines were only 37% and 23% effective, Vasad asked, “How much lower can it go — 10%? How low before Peter Marks says that’s too low?”
Vasad said if the adult vaccine becomes less effective over time, “tell me why that means you should accept the less effective kids’ vaccine?”
Vasad explained:
“If a therapy loses efficacy over time, why does that mean the bar to be a therapy is lower? It should mean that we need new therapies. We need a new mRNA construct.
“You need to kind of aim at the thing that’s actually out there now and not the original thing from two years ago. Maybe you want to rejigger your process. Try something new but it doesn’t mean we keep lowering the bar. This is ridiculous.”
Moderna reports concerning efficacy data for pediatric COVID-19 vaccines
As The Defender reported, Moderna on April 28 asked the FDA to approve its COVID-19 mRNA-1273 vaccine for children 6 months to 6 years old, citing different efficacy numbers than it disclosed in March.
The company conducted separate trials for two versions of the vaccine, one for infants and toddlers aged 6 months to 2 years, and one for children 2 to 6 years, and claimed data showed “a robust neutralizing antibody response” and “a favorable safety profile.”
Yet, Moderna’s KidCOVE study showed the company’s COVID-19 vaccine failed to meet the FDA’s minimum efficacy requirements for EUA in the 2- to under-6 age group, and barely surpassed the agency’s 50% efficacy requirement in the 6-month to 2-year age group — even after the vaccine maker changed its analysis of the study to meet the threshold.
Moderna also did not follow trial participants beyond 28 days, so vaccine effectiveness after that time is unknown. Data from New York state show vaccine effectiveness for the 5-to-11 age group plummets within seven weeks to 12%.
“Here, we’re looking only at the first four weeks,” Dr. Madhava Setty told The Defender. “Although data from New York were in a different age group using a different mRNA vaccine, the effectiveness was remarkably similar after four weeks. Why wouldn’t we expect that the same thing is going to happen?”
The House Select Subcommittee on Coronavirus Crisis on April 26 asked the FDA for a status update on COVID-19 vaccines for children under 5.
The agency said it was considering holding off on reviewing Moderna’s request to authorize its COVID-19 vaccine for children under 5 until it has data from Pfizer and BioNTech on their vaccine for children, pushing the earliest possible authorization of a vaccine from May to June.
When asked on Friday whether the FDA’s vaccine advisors would slow-roll Moderna’s applications and wait to review Pfizer’s and Moderna’s applications together, Marks said the meetings set for next month could move up if necessary.
“Obviously if we get through reviews faster, then we will send them to committees sooner,” Marks said.
According to Rep. Jim Clyburn’s (D-S.C.) account of the meeting, Marks said the FDA’s vaccine advisory committee has reserved earlier dates, enabling the agency to potentially “move dates up even by a week for any of these reviews.”
“At the end of the day, we want people to have confidence in getting vaccinated,” Marks said. “We need to get more kids vaccinated, not just in the younger than 5 age range, but also older than 5.”
Megan Redshaw is a staff attorney for Children’s Health Defense and a reporter for The Defender.
Russian gas conglomerate Gazprom has received no confirmation of force majeure or any obstacles to continued transit of gas through a junction in Lugansk Region, the company said on Tuesday, after Ukraine’s operator OGTSU announced it would halt further deliveries starting May 11, due to the presence of “Russian occupiers.”
Gas Transit Services of Ukraine (OGTSU) declared force majeure on Tuesday, saying that it was impossible to continue the transit of gas through a connection point and compressor station located in the Lugansk area. As OGTSU personnel “cannot carry out operational and technological control” over the Sokhranovka connector point and Novopskov compressor station, the company cannot continue to fulfill its contract obligations, it said.
Gas from this connection will not be accepted into the transit system of Ukraine starting at 7 am on Wednesday, OGTSU said. Sokhrankovka accounts for almost a third of the Russian gas that transits through Ukraine to Europe – up to 32.6 million cubic meters per day – according to the operators.
Gazprom has received no confirmation of force majeure or disruption of operations at Sokhranovka or Novopskov, company spokesman Sergey Kupriyanov said on Tuesday. He added that Ukrainian specialists have had full access to both facilities all along, and there had been no complaints about it previously.
Kupriyanov also said that Gazprom has been notified by Ukraine’s gas company Naftogaz that if Russia continues to supply gas through Sokhranovka, Kiev will reduce the volume at the point of exit by the same amount, effectively confiscating the gas.
While OGTSU has proposed to reroute the gas to Sudzha, a connector located in the Sumy region and controlled by the Ukrainian government, Kupriyanov said this was “technologically impossible.”
“The distribution of volumes is clearly spelled out in the cooperation agreement dated December 30, 2019, and the Ukrainian side is well aware of this,” he said.
Gazprom is fulfilling all of its obligations to its European customers, with all the transit services in accordance with the terms of the contract and paid in full, Kupriyanov pointed out. Moscow has continued gas deliveries to Europe, including transit through Ukraine, regardless of the ongoing military operation and the embargoes against Russia imposed by the US and its allies in the EU.
Once upon a time United States foreign policy was based on actual national interests, but that was long ago and far away before the country was beguiled into a colonial war with Spain followed by a twentieth century that was chock-a-block full of any type and intensity of warfare that one might imagine, including the use of nuclear weapons. Some might consider that the United States has become a nation made by war, to include a presumption that all the war-making has been both just and necessary, since America is “exceptional” and by default “the leader of the Free World.” Witness what is taking place vis-à-vis Ukraine and Russia right now, pressing forward with a full-scale economic war against Moscow while arming one of the belligerents in support of no actual national interest, as if by habit. The propensity of American politicians to resort to arms to compensate for their other failures is such that among circles in Washington and the media there has long been a joke making the rounds observing that no matter who is nominated and elected president we always wind up with John McCain. But if one is seriously concerned about the tendency of the United States to view nearly every foreign problem as solvable if only one uses enough military force, the joke might be updated to suggest that we Americans now always wind up with the Kagans, the first family of neoconservative/neoliberal advocates for an aggressive, interventionist US foreign policy.
Victoria Nuland, the architect of the disaster in Ukraine and a Dick Cheney and Hillary Clinton protege, is married to Robert Kagan and now serving as number three in the State Department. Robert is the Stephen & Barbara Friedman Senior Fellow with the Project on International Order and Strategy in the Foreign Policy program at Brookings and is also a regular contributing columnist at The Washington Post. His brother is Fred, currently a resident scholar at the American Enterprise Institute, and Fred’s wife Kimberley is head of the aptly named Institute for the Study of War.
When Congress-critters want to justify a new war, they frequently cite judgements made by one of the various groups associated with the Kagans. Robert is a frequent contributor to the national media both in interviews and opinion pieces calling inevitably for harsh measures against countries like Russia and Iran while Fred uses his bully pulpit to argue in favor of a large increases in military spending to counter “future threats.” Fred and Robert are members of the Aspen Strategy Group. They and their father, Donald, were all signatories to the neocon Project for the New American Century manifesto, Rebuilding America’s Defenses (2000).
Characteristically, the Kagan brothers love war but expect someone else to do the fighting. They are both considerably overweight and could never pass a military entrance physical if they were so inclined, which, of course they are not. The Kagans have been closely tied to the Democratic Party on many social issues and would likely describe themselves as liberal interventionists as well as neocons, since in practice both labels mean the same thing in terms of an assertive foreign policy backed by force. Plus, their flexibility gives them access to the foreign policy establishments of both major parties, as also does their support of Israeli interests in the Middle East, to include outspoken support of the Iraq War and for a covert war against Iran.
The Kagans are labeled by many as conservative, but they are not reliably Republican. Donald Trump was much troubled during his 2016 and 2020 campaigns by so-called conservatives who rallied behind the #NeverTrump banner, presumably in opposition to his stated intention to end or at least diminish America’s role in wars in the Middle East and Asia. The Kagans were foremost among those pundits. Robert was one of the first neocons to get on the #NeverTrump band wagon back in 2016 when he endorsed Hillary Clinton for president and spoke at a Washington fundraiser for her, complaining about the “isolationist” tendency in the Republican Party exemplified by Trump. Many other notable neocons also declared themselves to be #NeverTrump, including Bill Kristol, Bret Stephens, Daniel Pipes, Reuel Gerecht, Max Boot and Jonah Goldberg.
To be sure, some high-profile neocons stuck with the Republicans, to include the highly controversial Elliott Abrams, who initially opposed Trump but later became the point man for dealing with both Venezuela and Iran, attracted by Trump’s hardline with both countries. Abrams’ conversion reportedly took place when he realized that the new president genuinely embraced unrelenting hostility towards Iran in particular as exemplified by his ending of the Joint Comprehensive Plan of Action (JCPOA) and the assassination of Iranian general Qassem Soleimani in Baghdad. John Bolton was also for a time a neocon in the White House fold, though he later became an enemy after being fired by the president and then wrote a book critical of Trump.
Even though the NeverTrumper neocons did not succeed in blocking Donald Trump in 2016, they maintained relevancy by slowly drifting back towards the Democratic Party, which is where they originated back in the 1970s in the office of the Senator from Boeing Henry “Scoop” Jackson. A number of them started their political careers there, to include leading neocon Richard Perle.
It would not be overstating the case to suggest that the neoconservative movement together with its liberal interventionist colleagues are dominating foreign policy thinking across the board in Congress and the White House. That development has been aided by a more aggressive shift among the Democrats themselves, with Russiagate and other “foreign interference” still to this day being blamed for the party’s failure in 2016 and for its dreary prospects in midterm elections later this year. Given that mutual intense hostility to Trump, the doors to previously shunned liberal media outlets have now opened wide to the stream of foreign policy “experts” who want to “restore a sense of the heroic” to US national security policy. Eliot A. Cohen and David Frum have been favored contributors to the Atlantic while Bret Stephens and Bari Weiss were together at the New York Times prior to Weiss’s resignation. Jennifer Rubin, who wrote in 2016 that “It is time for some moral straight talk: Trump is evil incarnate,” is a frequent columnist for The Washington Post while both she and William Kristol appear regularly on MSNBC. Russian-Jewish import hardliner Max Boot is a regular feature contributor at the Post.
The unifying principle that ties many of the mostly Jewish neocons together is, of course, unconditional defense of Israel and everything it does, which leads them to support a policy of American global military dominance which they presume will inter alia serve as a security umbrella for the Jewish state. In the post-9/11 world, the neocon media’s leading publication Bill Kristol’s The Weekly Standardvirtually invented the concept of “Islamofascism” to justify endless war in the Middle East, a development that has killed millions of Muslims, destroyed at least three nations, and cost the US taxpayer more than $5 trillion. The Israel connection has also resulted in neocon political and media support for the currently highly aggressive and dangerous policy against Russia, due in part to its involvement in defense of Israeli target Syria. In Eastern Europe, neocon ideologues have aggressively exploited the largely illusory policy of “democracy promotion,” which, not coincidentally, has also been a major Democratic Party foreign policy objective, both coming together nicely to justify the current chaos in Ukraine.
The neocons and liberal interventionists are involved in a number of foundations, the most prominent of which is the Foundation for Defense of Democracies (FDD), that are largely funded by Jewish billionaires and defense contractors. FDD is headed by Canadian Mark Dubowitz and it is reported that the group takes direction coming from officials in the Israeli Embassy in Washington. Other major neocon incubators are the American Enterprise Institute, which currently is the home of Paul Wolfowitz, and the School of Advanced International Studies (SAIS) at John Hopkins University.
Many former Barack Obama White House senior officials who believe in liberal interventionism and democracy promotion while also hating Russia and Vladimir Putin have developed comfortable working relationships with the neocons. Foreign policy hawks including Antony Blinken, Wendy Sherman, Nicholas Burns, Susan Rice and Samantha Power are calling most of the shots given Biden’s senility but with neocon political and media support.
Unfortunately, nowhere in Biden’s foreign policy circle does one find anyone who is resistant to the idea of worldwide interventionism in support of claimed humanitarian objectives, even if it would lead to an actual shooting war with major competitor power Russia and also possibly China. In fact, Biden himself embraces a characteristically extremely bellicose view on a proper relationship with foreign nations “claiming that he is defending democracy against its enemies.” His language and authoritarian governing style leave no wiggle room for constructive dialogue with adversaries. The script being written by his Administration on how to deal with the rest of the world promises nothing but unending trouble and quite possibly sharp economic decline in the US for the foreseeable future.
Philip M. Giraldi, Ph.D., is Executive Director of the Council for the National Interest, a 501(c)3 tax deductible educational foundation (Federal ID Number #52-1739023) that seeks a more interests-based U.S. foreign policy in the Middle East. Website is councilforthenationalinterest.org, address is P.O. Box 2157, Purcellville VA 20134 and its email is inform@cnionline.org.
BERLIN – A study by the German Hans Böckler Foundation has now calculated that the gross domestic product (GDP) could collapse by up to twelve percent within the first year if Russian gas supplies were to end immediately. It is the latest doomsday prediction for Germany’s industry.
Industrial production would fall by 114 to 286 billion euros. This alone would lead to a GDP slump of three to eight percent, which would be increased by another two to four percent because the higher energy prices reduce the financial scope of consumers for other expenditures.
According to the study author Professor Tom Krebs from the University of Mannheim, a gas supply ban would only be manageable from 2025 onwards if other sources were available.
In addition, Krebs warned of so-called “cascade effects” that could also affect sectors that are less dependent on natural gas and threatened to “drastically” increase the economic damage. He also drew attention to the fact that the German economy is still under severe stress after the 2009 financial crisis, the 2020 Corona pandemic and due to self-inflicted climate change pressure. Since the expected price shocks for energy and food would have to be borne primarily by poorer households, “social tensions could intensify”.
The warnings of the study correspond exactly to what other experts have said: The former EON boss Johannes Teyssen had described a ban on Russian energy supplies as “highly dangerous” just last week.
Teyssen does not consider the suggestions of taking cold showers made by Economics Minister Robert Habeck and Federal Network Agency boss Klaus Müller to make any sense: “If it were about that and it could be regulated, then we would have done it a long time ago.”
In fact, it is “really about an extensive collapse of the basic industrial structure that needs natural gas and the entire value chain behind it”. One has to understand how it works. Supply bottlenecks would arise in other industries if large energy companies were no longer able to produce anything.
The general manager of the chemical industry association, Wolfgang Große Entrup, also issued almost identical warnings at the beginning of April. In the event of a short-term, unlimited stop in the supply of Russian gas, “a severe recession and a massive loss of jobs” must be expected. It is “frequently massively underestimated” that other branches of industry such as agriculture, construction, food, automobiles or electronics would then also be badly hit. For the loss of natural gas there is “no short-term replacement option”.
Yet these industry heavyweights are totally ignored by EU chief Ursula von der Leyen, and the irresponsible demands of the Ukrainian Ambassador Andriy Melnyk or “Fridays-for-Future” activist Luisa Neubauer, goading Germany into an economic catastrophe, the consequences of which must be shouldered by ordinary citizens – and not by the privileged, wealthy or state-appointed authors of the measures.
“You hear so little about Gretl, the little climate siren from Sweden. No screaming ‘how dare you’, no shouting on our streets, the blond braided one has dedicated herself to inner emigration. The Fridays for Future sect, the radical arm of the eco-socialists, plays the ostrich. The hip Greta has fallen silent in the face of the honorable rearmament of the Western arms industry,” noted Austrian politician Gerald Grosz.
“Yes, the good girl believes that the F16 flies on an e-battery on its way to the Ukraine. Or does she believe that the atomic bombs are powered by solar panels and that only ‘organic makes you beautiful’ soybeans grow after the impact. And the artillery pieces move on rapeseed oil?”
A poll published on Saturday found that 53% of Americans believe that sanctions on Moscow hurt the US more than Russia. Amid soaring gas prices and a rising cost of living, voters are losing confidence in US President Joe Biden’s leadership, and 43% say they’re “OK” with Ukraine losing its ongoing conflict with Russia.
With inflation at a 40-year peak and gas prices near record highs, the Democracy Institute/Express.co.uk poll revealed that Biden is polling negatively in all policy areas, with foreign policy the worst. Some 56% disapprove of his handling of foreign matters, compared to 40% approving. On Ukraine specifically, only 38% approve of his stewardship, while 52% disapprove.
The Biden administration has attempted to blame Russia and its president, Vladimir Putin, for the rising cost of living at home, with his officials repeatedly referring to “Putin’s price hike.” However, living costs were rising for months before Russia sent troops into Ukraine, and voters are pointing the finger at Biden for their economic woes.
Some 50% said they’d back Republicans in November’s midterm elections, compared with 42% saying they’d vote Democrat. In addition to more voters being “OK” than “not OK” with Ukraine losing the conflict with Russia (43%-41%), more Americans think it would be better for Biden to leave office than for Putin to step down, by 53% to 44%.
Biden has sanctioned the Russian banking and energy sectors, and his administration has sent nearly $4 billion worth of weapons to Ukraine, with Defense Secretary Lloyd Austin promising last month to “move heaven and earth” to finance Kiev’s fighting. The US president has also asked Congress to approve another $33 billion aid package for Ukraine – of which $20 billion would be earmarked for military aid – and on Monday signed the Lend-Lease Act of 2022, allowing Washington to send unlimited quantities of arms to Kiev.
In the eyes of the Kremlin, this deluge of weapons plus the US and NATO’s intelligence-sharing arrangements with Kiev mean that the West is “essentially going to war with Russia through a proxy.”
American voters, however, are not as earnest as the Biden administration in fuelling this war. According to the latest poll, they consider Russia the fourth biggest threat to the US at 16%, behind North Korea (18%), Iran (20%), and China (40%).
“Americans were very pro sanctions at first, [but] they are not as keen on the sanctions as they were,” Democracy Institute Director Patrick Basham told Express. “Biden made these predictions at the outset – the ruble would be rubble, we were going to crash the Russian economy, people will rise up, Putin will be out, the Russians will run away from Ukraine … [but] none of those things have happened.”
This difference between expectation and reality has made people cynical, he claimed, comparing the apparent loss of trust to public disillusionment with coronavirus policies throughout the West.
“The problem [now] is that at least half of the country in America thinks they were hoodwinked over a lot of the Covid stuff, so they are even more cynical about government and media than they were two years ago,” he said.
The US asked Brazil in March to increase its crude oil output to curb soaring prices amid international sanctions against Russia, but Brazil refused, Reuters reported on Tuesday.
US government officials approached Brazil’s state-run oil company Petrobras, the outlet quoted its sources as saying, as crude prices started to rise against the backdrop of Russia’s military operation in Ukraine and the ensuing international sanctions.
The officials came away empty-handed, however, as Petrobras said that output levels were determined by business strategy rather than diplomacy and also that a significant short-term production boost would not be logistically possible, Reuters says.
Brazil is the world’s 11th largest oil exporter, with most of its crude going to China, the US, and India, according to the Observatory of Economic Complexity (OEC).
Also in March, the US approached Venezuela, which has the world’s largest proven oil reserves, offering to ease some of the sanctions on the country in exchange for increased oil exports to the US. However, Washington later backtracked on the issue.
Washington banned the import of Russian oil in early March, with US Energy Secretary Jennifer Granholm saying that the country was on “war footing,” and calling on domestic producers to boost output. Last year, the US got 8% of its total petroleum imports from Russia, according to the US Energy Information Administration, with other major suppliers being Canada, Mexico, and Saudi Arabia.
The U.S. Food and Drug Administration granted fast track designation to UB-311, a vaccine for Alzheimer’s disease made by biotechnology company Vaxxinity.1 The shot is an anti-amyloid beta immunotherapeutic vaccine that reportedly treats Alzheimer’s disease by targeting aggregated amyloid beta in the brain.2
Aside from the potential problems that can arise when a vaccine is rushed to market, the vaccine may be problematic from the get-go because amyloid beta may be a symptom of Alzheimer’s — not the cause — and could even have a protective role in the disease process.3
Fast-tracking a vaccine that’s targeting an isolated element of Alzheimer’s disease that is not the underlying cause is destined to be a massive disaster.
Alzheimer’s Vaccine Being Fast-Tracked to Market
UB-311 is being touted for eliciting a “robust and durable anti-amyloid beta antibody responses in patients,” according to Vaxxinity.4 Phase 1, Phase 2a and Phase 2a long-term extension trials have already been completed, with the company stating that the vaccine was “well tolerated in mild-to-moderate AD patients over three years of repeat dosing, with a safety profile comparable to placebo and no cases of amyloid-related imaging abnormalities-edema (“ARIA-E”) in the main study.”5
ARIA-E, a marker of fluid retention and microhemorrhages in the brain, occurs in about one-third of people taking the Alzheimer’s drug aducanumab (brand name Aduhelm).6 Similar to UB-311, Aduhelm was brought to market under an accelerated approval pathway by the FDA, despite uncertainty about the clinical benefit.7 The action sparked protests within the FDA advisory panel, and three members subsequently resigned.8
As an amyloid beta-directed antibody drug, Aduhelm also works by targeting amyloid beta in the brains of people with Alzheimer’s disease, but the findings of ARIA-E in many taking the drugs are alarming. Adam Brickman with Columbia University, New York City, suggested that the drug could potentially make cognitive decline worse instead of better. “It’s hard to put a positive spin on the neuroimaging abnormalities,” he wrote. “… [W]e simply do not know the long-term consequences.”9
While Vaxxinity is touting no cases of ARIA-E among its subjects as a success, the same holds true about the vaccine in that no one knows the long-term consequences. Vaxxinity has planned a Phase 2b trial for late 2022.10 It’s worth noting that drug development for Alzheimer’s has so far been a dismal failure, with at least 300 failed trials to date.11
One study, which was a collaboration between Washington University in St. Louis, drug companies Eli Lilly and Roche, the National Institutes of Health and others, involved 194 participants, of which 52 took Roche’s drug gantenerumab and 52 took Eli Lilly’s solanezumab.12
The drugs were intended to remove amyloid beta (Aβ) from the brain, but they failed to achieve the primary outcome of the study, which was slowed cognitive decline, as measured by tests on thinking and memory.
In fact, while the drugs did target amyloid beta, they had no effect on cognitive measures, with the researchers writing, “Both drugs engaged their Aβ targets but neither demonstrated a beneficial effect on cognitive measures compared to controls.”13
Is Amyloid Beta the Problem?
Even if drugs reduce amyloid beta plaques in Alzheimer’s patients, how this translates to affecting cognitive decline remains to be seen. While Alzheimer’s is characterized by an accumulation of beta-amyloid plaques and neurofibrillary tangles in the brain, there is controversy over their role in the development of the disease.
As researchers from the Tokyo Metropolitan Institute of Medical Science, department of dementia and higher brain function, wrote in Frontiers in Neuroscience :14
“The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or fibrillar amyloid β (Aβ) peptide is the primary cause of Alzheimer’s disease (AD), has been the mainstream concept underlying AD research for over 20 years. However, all attempts to develop Aβ-targeting drugs to treat AD have ended in failure.”
In 2009, researchers brought attention to the misguided premise of oversimplifying Alzheimer’s disease down to the amyloid-β protein precursor (AβPP) molecule, “implying that this molecule encapsulates AD so completely that the disease itself is almost of secondary importance.” This, they noted, ignores “the complexity of chronic diseases in general” and added:15
“A great deal of attention has focused on amyloid-β as the major pathogenic mechanisms with the ultimate goal of using amyloid-β lowering therapies as an avenue of treatment. Unfortunately, nearly a quarter century later, no tangible progress has been offered, whereas spectacular failure tends to be the most compelling.
We have long contended, as has substantial literature, that proteinaceous accumulations are simply downstream and, often, endstage manifestations of disease.
Their overall poor correlation with the level of dementia, and their presence in the cognitively intact is evidence that is often ignored as an inconvenient truth. Current research examining amyloid oligomers, therefore, will add copious details to what is, in essence, a reductionist distraction from upstream pleiotrophic processes such as oxidative stress, cell cycle dysfunction, and inflammation.
It is now long overdue that the neuroscientists avoid the pitfall of perseverating on ‘proteinopathies’ and recognize that the continued targeting of end stage lesions in the face of repeated failure, or worse, is a losing proposition.”
Amyloid Beta May Be Protective
There is even research to suggest that advanced protein aggregation, such as that seen in Alzheimer’s disease, could offer protective functions, perhaps protecting cells from toxic intermediates.16 Writing in the Annals of the New York Academy of Sciences, researchers suggested that amyloid beta is a response to neuronal stress, one that functions as a protective adaptation to the disease.17
Amyloid beta, they argued, accumulates relatively late in the development of Alzheimer’s disease, and while it has been found to be toxic in cell culture models, this may not hold true in humans. Instead of the prevailing notion that a mutation leads to increased amyloid beta and that leads to Alzheimer’s, the team suggested that a mutation leads to Alzheimer’s, which in turn triggers increased amyloid beta:18
“Mutations lead to cellular stress, which, in turn, leads to increased amyloid-β … in AD, cellular stress precedes increases in amyloid-β … Proteins, such as amyloid-β, that are induced under oxidative conditions and act to lessen oxidative damage are typically thought of as antioxidants and, in this regard, we recently demonstrated that amyloid-β is a bona fide antioxidant that can act as a potent superoxide dismutase.”
This would explain, they suggest, why the brains of most elderly people contain amyloid-β, often in amounts similar to those found in patients with Alzheimer’s disease (AD). They noted:19
“While such production and deposition of amyloid-β appears to successfully stave off age-related redox imbalances in normal aging, in AD, where there is a profound and chronic redox imbalance, the presence of amyloid-β, even at high levels, proves insufficient.”
The Link Between Alzheimer’s and Your Gut
If Alzheimer’s pathogenesis cannot be blamed entirely on amyloid beta, what, then, is the cause? It’s likely that many factors are to blame, with imbalances in gut microbiota among them. Research suggests, for example, that the bacteria in your intestines may influence brain functioning and can even promote neurodegeneration.20
In a study of 89 people, high blood levels of lipopolysaccharides (LPSs) and the short-chain fatty acids (SCFAs) acetate and valerate were associated with large amyloid deposits in the brain.21 LPSs and SCFAs are markers of inflammation and proteins produced by intestinal bacteria.
High levels of butyrate — an SCFA produced when gut bacteria ferment fiber —were associated with less amyloid. The study represents a continuation of prior research by the team, which found that the gut microbiota in people with Alzheimer’s disease differs from those without the condition; in those with Alzheimer’s, microbial diversity is reduced, with certain bacteria being overrepresented and other microbes decreased.22
“Our results are indisputable: certain bacterial products of the intestinal microbiota are correlated with the quantity of amyloid plaques in the brain,” explains Moira Marizzoni, a study author with the Fatebenefratelli Center in Brescia, Italy.23
Still other research suggests gut microbiota may contribute to Alzheimer’s risk via multiple avenues, including by influencing aging, diabetes, sleep and circadian rhythm.24
It’s also possible, researchers hypothesize, that decades of factors such as diet, stress, aging and genetics, combine to disrupt gut permeability and the integrity of the blood-brain barrier, allowing the entry of inflammatory agents and pathogens and inducing an inflammatory response that triggers a neuroinflammatory response in the brain.25
There’s More to Alzheimer’s Than Amyloid Beta
UB-311 — the fast-tracked Alzheimer’s vaccine — is not going to touch the many complex factors leading to the development of Alzheimer’s disease and is likely to have unintended adverse consequences. Dietary factors, for instance, are being completely overlooked by focusing on a vaccine to target amyloid beta.
Not only does what you eat affect your gut health but it also impacts cholesterol, and cholesterol also plays an important role in the formation of memories and is vital for healthy neurological function. As noted by senior research scientist Stephanie Seneff, Ph.D., insufficient fat and cholesterol in your brain play a crucial role in the Alzheimer’s disease process, detailed in her 2009 paper “APOE-4: The Clue to Why Low Fat Diet and Statins May Cause Alzheimer’s.”26
Time-restricted eating is another important strategy, as is reducing your intake of polyunsaturated fatty acids, also called PUFAs, found in vegetable oils, edible oils, seed oils, trans fat and plant oils. For a more targeted approach, natural options are available.
Animal and laboratory studies demonstrate that the spice saffron is neuroprotective, for instance. Data also show it is as effective as the drug memantine to treat moderate to severe Alzheimer’s disease.27 One of the most comprehensive assessments of Alzheimer’s risk is Dr. Dale Bredesen’s ReCODE protocol, which evaluates 150 factors, including biochemistry, genetics and historical imaging, known to contribute to Alzheimer’s disease.
In his book, “The End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline,”28 which describes the complete protocol, you will also find a list of suggested screening tests and the recommended ranges for each test, along with some of Bredesen’s treatment suggestions.
Overall, nourishing your brain health is best done with a comprehensively healthy lifestyle. By leveraging 36 healthy lifestyle parameters, Bredesen was able to reverse Alzheimer’s in 9 out of 10 patients.
This included the use of exercise, ketogenic diet, optimized vitamin D and other hormones, increased sleep, meditation, detoxification and the elimination of gluten and processed food. For more details, you can download Bredesen’s full-text case paper online, which details the full program.29
Germany and Qatar have failed to reach an agreement regarding long-term liquefied natural gas (LNG) supply contracts, Reuters reported on Tuesday, citing people close to the talks.
According to the outlet, Berlin will not agree to Qatar’s demand to sign deals for a duration of at least 20 years. Despite seeking to end its reliance on Russian natural gas amid the situation in Ukraine, Berlin reportedly views this timeframe as contradicting its plan to slash carbon emissions by 88% by 2040.
“The issue of LNG contract length potentially putting Germany’s decarbonization targets at risk is part of the ongoing discussions with Qatar,” one of the sources told Reuters, noting that Germany is not the only nation eager to secure LNG supplies from Qatar.
Qatar also wants to contractually prevent Germany from rerouting the LNG deliveries to other European states, and this measure is not welcome by the EU, the sources said.
One of the sources told the publication that the LNG deal between Qatar and Germany “is not expected to happen soon.”
Qatar is the world’s largest LNG supplier. Major German power producer RWE already has a deal with Qatargas dating back to 2016 for 1.1 million tons of LNG annually until the end of 2023. RWE officials, as well as representatives from another German utility, Uniper, and German Economy Minister Robert Habeck visited Qatar in March to secure additional volumes of LNG supplies, but have not agreed on a long-term deal so far.
The delegation is set to return to Qatar later this month to resume negotiations, according to Reuters sources. They claim that Germany aims to reach a two-way partnership with Qatar, exchanging additional LNG supply contracts for assistance from German firms in the Qatari move toward sustainability.
“There needs to be a gentlemen’s agreement between the Qataris and German companies, that LNG should only be the first step in a longer collaboration between the two countries,” an unnamed German industry source said.
The number of Swedish adults diagnosed with mild forms of intellectual disability has increased sharply.
A review of statistics from the National Board of Health and Welfare by the trade newspaper Psykologtidningen has indicated that that the number of adult patients with mild forms of retardation has more than doubled, increasing by 143 percent, between the years 2008 and 2020.
In concrete figures, the number of adults diagnosed during this period increased from 1,133 to 3,114 people.
In some extreme cases, like the city of Örebro, the increase has been measured at an incredible 617 percent.
The National Board of Health and Welfare has no explanation for the spike.
“Obviously there has been an increase. It is therefore important to have a closer look at this,” Peter Salmi, a psychiatric investigator at the National Board of Health and Welfare, said in a statement.
According to Salmi, one possible explanation for the rise could be the fact that the diagnosis manual was updated in 2013. Before that, people with an IQ below 70 were automatically classified as mildly retarded. However, since then more importance is placed on how they function in everyday life and between 2013 and 2020, the number of diagnoses “only” increased by 37 percent.
Salmi further explained that investigations for ADHD and autism have increased in recent years, and those surveys include an aptitude test, which may have increased the number of diagnoses.
Mild intellectual disability (also referred to as mild developmental disorder) occurs in between 0.5 and 1.5 percent of the population. It implies shortcomings in theoretical thinking and learning. The affected individual perceives the outside world in a more concrete way and has difficulties understanding abstract words, symbols and descriptions.
Psychiatric drugs lead to the deaths of over 500,000 people aged 65 and over annually in the West, a Danish scientist says. He warns the benefits of these drugs are “minimal,” and have been vastly overstated.
Research director at Denmark’s Nordic Cochrane Centre, Professor Peter Gøtzsche, says the use of most antidepressants and dementia drugs could be halted without inflicting harm on patients. The Danish scientist’s views were published in the British Medical Journal on Tuesday.
His scathing analysis will likely prove controversial among traditional medics. However, concern is mounting among doctors and scientists worldwide that psychiatric medication is doing more harm than good. In particular, they say antipsychotic drugs have been over-prescribed to many dementia patients in a bid to calm agitated behavior.
Gøtzsche warns psychiatric drugs kill patients year in year out, and hold few positive benefits. He says in excess of half a million citizens across the Western world aged 65 and over die annually as a result of taking these drugs.
“Their benefits would need to be colossal to justify this, but they are minimal,” he writes.
“Given their lack of benefit, I estimate we could stop almost all psychotropic drugs without causing harm.”
Gøtzsche, who is also a clinical trials expert, says drug trials funded by big pharmaceutical companies tend to produce biased results because many patients took other medication prior to the tests.
He says patients cease taking the old drugs and then experience a phase of withdrawal prior to taking the trial pharmaceuticals, which appear highly beneficial at first.
The Danish professor also warns fatalities from suicides in clinical trials are significantly under-reported. … continue
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.